RRP43 Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Applications of RRP43 Antibody

RRP43 antibodies are immunological reagents targeting the RRP43 protein (UniProt ID: Q96B26 in humans), a core subunit of the RNA exosome complex. These antibodies are widely used in:

  • Western blotting: Detects RRP43 at ~34 kDa in human HEK-293T and HeLa cell lysates .

  • Immunoprecipitation: Identifies protein-protein interactions, such as RRP43's binding to Rrp46p in yeast .

  • Immunofluorescence: Localizes RRP43 to the nucleolus, nucleoplasm, and cytoplasm .

Biological Role of RRP43

RRP43 is essential for:

  • RNA degradation: Facilitates 3'-5' exoribonuclease activity in the nuclear and cytoplasmic exosome .

  • Pre-rRNA processing: Required for 5.8S rRNA maturation and 27S pre-rRNA cleavage in Saccharomyces cerevisiae .

  • mRNA stability: Depletion in yeast (rrp43-ts mutants) increases mRNA half-lives (e.g., ACT1 mRNA from 20 to 40 minutes) .

Key Functional Domains:

  • Central region (aa 162–276): Critical for thermostability and exosome interactions. Mutations here (e.g., Val212Ala, Ser162Phe) impair RNA processing .

  • RNase PH-like domain: Shares homology with bacterial RNase PH but lacks direct catalytic activity .

Table 2: Key Studies on RRP43 Dysfunction

Model SystemFindingsCitation
Yeast (rrp43-ts mutants)- Accumulates 23S pre-rRNA and stabilizes mRNA degradation intermediates .
- Disrupted Rrp43p-Rrp46p interaction impairs exosome assembly .
Human cells (EXOSC8 mutants)- Reduced mitochondrial respiration and cytochrome levels due to defective RNA surveillance .
- Linked to pontocerebellar hypoplasia and neurodegeneration .
B lymphocytes- RRP43 associates with AID during class-switch recombination, linking exosome activity to antibody diversity .

Mechanistic Insights from Yeast Models

  • Temperature-sensitive mutants (rrp43-1, rrp43-2, rrp43-3):

    • Show allele-specific defects: rrp43-2 (Cys230Tyr/Ile274Thr) accumulates aberrant 23S pre-rRNA, while rrp43-3 (Ser162Phe) destabilizes 20S pre-rRNA .

    • Prolong mRNA half-lives (e.g., CATpG reporter mRNA from 37 to 65 minutes) .

  • Interaction network: Rrp43p binds Rrp46p, forming a structural node essential for exosome integrity .

Implications in Disease

  • Neurodegeneration: EXOSC8 (human RRP43) mutations disrupt mitochondrial RNA metabolism, leading to oxidative phosphorylation defects .

  • Cancer: Dysregulated exosome activity alters mRNA stability, potentially influencing oncogene expression .

Considerations for Experimental Use

  • Cross-reactivity: Anti-RRP43 antibodies may recognize paralogs (e.g., mouse EXOSC8, UniProt Q9D753) .

  • Controls: Use rrp43-ts yeast strains or EXOSC8-depleted cells to validate antibody specificity .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
RRP43 antibody; YCR035C antibody; YCR35C antibody; YCR522 antibody; Exosome complex component RRP43 antibody; Ribosomal RNA-processing protein 43 antibody
Target Names
RRP43
Uniprot No.

Target Background

Function
RRP43 is a non-catalytic component of the RNA exosome complex. The RNA exosome complex exhibits 3'->5' exoribonuclease activity and plays a crucial role in various cellular RNA processing and degradation events. Within the nucleus, the RNA exosome complex participates in the proper maturation of stable RNA species, such as rRNA, snRNA, and snoRNA. It also eliminates RNA processing by-products and non-coding transcripts, including antisense RNA species and cryptic unstable transcripts (CUTs). Additionally, it degrades mRNAs with processing defects, thereby limiting or preventing their export to the cytoplasm. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and RNA surveillance pathways, ensuring the prevention of translation of aberrant mRNAs. The catalytic inactive RNA exosome core complex, consisting of 9 subunits (Exo-9), is thought to be critical for binding and presenting RNA for degradation. It acts as a scaffold for the association with catalytic subunits and accessory proteins or complexes. RRP43 is part of the hexameric ring of RNase PH domain-containing subunits, which is proposed to form a central channel through which RNA substrates are threaded for degradation.
Database Links

KEGG: sce:YCR035C

STRING: 4932.YCR035C

Protein Families
RNase PH family
Subcellular Location
Cytoplasm. Nucleus, nucleolus.

Q&A

What is RRP43 and what cellular functions does it participate in?

RRP43 (Ribosomal RNA Processing protein 43) is an essential subunit of the exosome complex involved in RNA processing and degradation pathways. In Saccharomyces cerevisiae, Rrp43p has been identified as a component of the exosome through co-purification studies with ProtA-Rrp4p . This protein participates in both pre-rRNA processing and mRNA degradation, making it crucial for multiple aspects of RNA metabolism.

Functionally, Rrp43p shows sequence similarity to Escherichia coli RNase PH, suggesting a potential role in phosphorolytic RNA degradation, though direct RNase activity has not been demonstrated for Rrp43p itself . Studies with temperature-sensitive mutants have confirmed that Rrp43p is required for proper mRNA decay in yeast, as evidenced by extended mRNA half-lives and accumulation of degradation intermediates in mutant strains .

In which cellular compartments is RRP43 found and how does this affect antibody selection?

Subcellular localization studies have detected Rrp43p in multiple cellular compartments including the nucleolus, nucleoplasm, and cytoplasm . This broad distribution reflects its diverse functions in RNA metabolism. While the nucleolar and nuclear fractions of Rrp43p primarily function in pre-rRNA processing and degradation of excised spacer sequences, the cytoplasmic fraction is involved in mRNA degradation pathways .

When selecting antibodies for RRP43 detection, researchers should consider this multi-compartmental distribution. Antibodies that recognize epitopes that remain accessible in different cellular environments and under various experimental conditions (such as different fixation methods) are preferable. For compartment-specific studies, researchers should validate the antibody's specificity in subcellular fractionation experiments followed by western blotting.

What experimental models are commonly used to study RRP43 function?

The primary experimental model for studying RRP43 function has been Saccharomyces cerevisiae. Several specialized yeast strains have been developed for this purpose, as shown in the table below:

StrainRelevant characteristicsPrimary application
DG458rrp43::KAN with GAL-regulated ProtA::RRP43Controlled expression studies
YCO44Wild-type RRP43 control strainBaseline comparison
rrp43-1Temperature-sensitive mutantmRNA decay/pre-rRNA processing studies
rrp43-2Temperature-sensitive mutantmRNA decay/pre-rRNA processing studies
rrp43-3Temperature-sensitive mutantmRNA decay/pre-rRNA processing studies
L40-based strainsTwo-hybrid system hostsProtein-protein interaction studies

These experimental models, particularly the temperature-sensitive mutants (rrp43-1, rrp43-2, and rrp43-3), have been invaluable for dissecting RRP43's role in RNA metabolism under controlled conditions .

How can RRP43 antibodies be used to study interactions within the exosome complex?

RRP43 antibodies can be employed in co-immunoprecipitation (co-IP) experiments to investigate interactions within the exosome complex. Two-hybrid analyses have revealed that Rrp43p interacts with the exosome complex primarily through Rrp46p . This specific interaction provides a crucial point for antibody-based studies.

When designing co-IP experiments with RRP43 antibodies, researchers should consider:

  • Using mild lysis conditions to preserve native protein complexes

  • Including appropriate controls to verify specificity (such as IgG controls)

  • Performing reciprocal IPs with antibodies against suspected interacting partners

  • Validating results with alternative methods such as proximity ligation assays

Based on two-hybrid analyses, researchers should expect to co-precipitate Rrp46p strongly, while other exosome subunits may be detected as part of the larger complex rather than through direct interaction with Rrp43p .

What insights can RRP43 antibodies provide about mRNA degradation pathways?

RRP43 antibodies can be instrumental in elucidating mRNA degradation pathways, particularly when used in combination with temperature-sensitive mutant strains. Research has shown that rrp43 temperature-sensitive mutants exhibit significantly extended mRNA half-lives compared to wild-type strains, as shown in the following data:

mRNAWild-type half-life (min)rrp43-1 half-life (min)rrp43-2 half-life (min)rrp43-3 half-life (min)
ACT120~4032~40
CATpG37526562

Studies with the CATpG reporter mRNA, which contains a poly(G) segment that impairs 5'→3' degradation, revealed that rrp43 mutants accumulate a degradation intermediate corresponding to the poly(G) fragment . This finding suggests that Rrp43p functions in the 3'→5' mRNA decay pathway.

By using RRP43 antibodies to deplete the protein or to analyze its association with specific mRNAs (through techniques like RNA immunoprecipitation), researchers can further dissect its role in various decay pathways.

How do mutations in RRP43 affect pre-rRNA processing, and how can this be analyzed?

Mutations in RRP43 lead to specific defects in pre-rRNA processing, which can be analyzed using RRP43 antibodies in conjunction with RNA analysis techniques. In temperature-sensitive rrp43 mutants, the following pre-rRNA processing defects have been observed:

  • Accumulation of aberrant 23S pre-rRNA

  • Defects in 27S pre-rRNA processing

  • Reduced formation of 20S pre-rRNA

  • Defects in 3'-end formation of 5.8S rRNA

Interestingly, different rrp43 mutant alleles can show distinct phenotypes. For example, in strain rrp43-3, 20S pre-rRNA levels decrease after prolonged incubation at restrictive temperature without a corresponding increase in 23S pre-rRNA, suggesting possible destabilization of 20S pre-rRNA. In contrast, strain rrp43-2 shows a higher 23S:20S ratio due to increased aberrant 23S pre-rRNA concentration .

For comprehensive analysis, researchers should combine:

  • Northern blot analysis of steady-state RNA levels

  • Pulse-chase labeling with [methyl-³H]methionine

  • RNA immunoprecipitation with RRP43 antibodies to identify associated pre-rRNAs

What are the optimal conditions for RRP43 antibody validation in yeast systems?

Proper validation of RRP43 antibodies is essential for reliable experimental results. The following protocol is recommended for comprehensive validation:

  • Specificity testing: Compare immunoblotting results between wild-type strains and rrp43 deletion strains complemented with plasmid-borne RRP43 (e.g., strain DG458) .

  • Epitope accessibility assessment: Test antibody performance in different subcellular fractions since Rrp43p is present in multiple compartments.

  • Cross-reactivity evaluation: Test against strains expressing epitope-tagged versions of RRP43 (such as HA-RRP43) to confirm specific recognition .

  • Functional validation: Confirm that antibody binding doesn't interfere with RRP43 function by performing immunoprecipitation followed by functional assays of the precipitated complex.

  • Immunodepletion controls: Perform sequential immunoprecipitations to confirm complete depletion of the target protein.

Including appropriate controls is critical - wild-type strains, deletion mutants, and strains expressing tagged versions of RRP43 (as shown in the plasmid table below) provide essential reference points.

PlasmidRelevant characteristicsValidation application
pCFUS-HARRP43MET25::HA-RRP43, CEN6, URA3Positive control for epitope-tagged RRP43
pCFUS-HArrp43-1MET25::HA-rrp43-1, URA3, CEN6Mutant control for specificity testing
pCFUS-HArrp43-2MET25::HA-rrp43-2, URA3, CEN6Mutant control for specificity testing
pCFUS-HArrp43-3MET25::HA-rrp43-3, URA3, CEN6Mutant control for specificity testing

What is the recommended protocol for immunoprecipitation of RRP43 and its associated RNAs?

RNA immunoprecipitation (RIP) using RRP43 antibodies can reveal the RNA species associated with RRP43 in vivo. The following protocol is optimized for this application:

  • Cell preparation:

    • Harvest yeast cells during logarithmic growth phase

    • Crosslink with 1% formaldehyde for 10 minutes at room temperature if studying transient interactions

    • Prepare cell lysates using a buffer containing 50 mM HEPES pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, and RNase inhibitors

  • Immunoprecipitation:

    • Pre-clear lysate with Protein A/G beads for 1 hour at 4°C

    • Incubate pre-cleared lysate with RRP43 antibody overnight at 4°C

    • Add fresh Protein A/G beads and incubate for 2-3 hours at 4°C

    • Wash extensively with lysis buffer followed by higher stringency washes

  • RNA recovery and analysis:

    • Reverse crosslinks if applicable (65°C for 1 hour in presence of proteinase K)

    • Extract RNA using phenol-chloroform method

    • Analyze by northern blotting, qRT-PCR, or RNA sequencing

This protocol is particularly effective for studying RRP43's association with pre-rRNAs and mRNAs undergoing degradation. For temperature-sensitive mutants, perform the procedure after shifting to non-permissive temperature for 2-4 hours to observe changes in RNA association patterns .

How can researchers distinguish between RRP43's nuclear and cytoplasmic functions using antibody-based approaches?

Distinguishing between the nuclear and cytoplasmic functions of RRP43 requires specialized antibody-based approaches that focus on spatial separation and functional analysis:

  • Subcellular fractionation combined with immunoblotting:

    • Prepare nuclear, nucleolar, and cytoplasmic fractions using established protocols

    • Perform western blotting with RRP43 antibodies on each fraction

    • Include compartment-specific markers (e.g., histone H3 for nucleus, α-tubulin for cytoplasm)

    • Quantify relative RRP43 levels in each compartment

  • Immunofluorescence microscopy with co-localization analysis:

    • Fix cells using methods that preserve nuclear architecture (e.g., 4% paraformaldehyde)

    • Perform immunofluorescence using RRP43 antibodies alongside compartment markers

    • Conduct quantitative co-localization analysis

    • Compare wild-type localization patterns with those in mutant strains

  • Compartment-specific functional assays:

    • Nuclear function: Analyze pre-rRNA processing defects after nuclear depletion

    • Cytoplasmic function: Monitor mRNA decay rates after cytoplasmic depletion

    • Compare results with those from temperature-sensitive mutants to identify compartment-specific phenotypes

The most effective approach combines these methods with genetic strategies, such as using mutants with altered nuclear/cytoplasmic distribution or mutations that specifically affect one compartment's functions while preserving the other's.

What are the critical parameters for western blotting with RRP43 antibodies?

Successful western blotting with RRP43 antibodies requires attention to several critical parameters:

  • Sample preparation:

    • Use fresh cell lysates prepared with protease inhibitors

    • For yeast samples, glass bead lysis in buffer containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100 is effective

    • Include both denatured total cell lysates and native immunoprecipitated samples for comparison

  • Electrophoresis conditions:

    • 10-12% SDS-PAGE gels provide optimal resolution for Rrp43p

    • Include positive controls such as lysates from strains expressing HA-tagged RRP43

    • Use temperature-sensitive mutant strains as additional controls

  • Transfer and detection optimization:

    • PVDF membranes with 0.45 μm pore size are recommended

    • Block with 5% non-fat dry milk in TBST

    • Primary antibody dilutions of 1:1000-1:5000 are typically effective

    • Include both chemiluminescent detection and fluorescent secondary antibodies for quantitative analysis

  • Validation controls:

    • Include wild-type, deletion mutant complemented with plasmid-borne RRP43, and epitope-tagged strains

    • For mutant analysis, compare samples before and after temperature shift

By optimizing these parameters, researchers can achieve reliable and reproducible detection of RRP43 in various experimental contexts.

How can researchers effectively use RRP43 antibodies to analyze protein-protein interactions within the exosome complex?

To effectively analyze protein-protein interactions within the exosome complex using RRP43 antibodies, researchers should implement a multi-faceted approach:

  • Sequential co-immunoprecipitation:

    • Perform initial IP with RRP43 antibody

    • Elute under mild conditions

    • Conduct second IP with antibodies against other exosome components

    • This approach can confirm direct interactions versus indirect complex associations

  • Crosslinking immunoprecipitation:

    • Use protein crosslinkers such as DSP (dithiobis[succinimidylpropionate]) to stabilize complexes

    • Perform IP with RRP43 antibodies

    • Analyze by mass spectrometry to identify associated proteins

    • Compare results with two-hybrid data showing that Rrp43p interacts primarily with Rrp46p

  • Proximity-based interaction analysis:

    • Employ techniques such as proximity ligation assay (PLA)

    • Combine RRP43 antibodies with antibodies against other exosome components

    • Quantify interaction signals in different cellular compartments

  • Competitive binding assays:

    • Use recombinant or purified exosome components to compete with native interactions

    • Assess how these competitors affect RRP43 antibody precipitation of the complex

    • This approach can help map the interaction surface

Based on two-hybrid analyses, researchers should focus particularly on the RRP43-RRP46 interaction, as this appears to be the primary connection between RRP43 and the rest of the exosome complex .

What are common issues in RRP43 immunoprecipitation experiments and how can they be resolved?

Researchers frequently encounter several challenges when performing immunoprecipitation with RRP43 antibodies. Here are the most common issues and their solutions:

  • Low IP efficiency:

    • Problem: Insufficient recovery of RRP43 protein

    • Solutions:

      • Increase antibody concentration or incubation time

      • Optimize lysis conditions to ensure complete solubilization

      • Pre-clear lysates more thoroughly to reduce non-specific binding

      • Consider using tagged versions of RRP43 if native antibody efficiency is consistently low

  • Loss of protein interactions:

    • Problem: Failure to co-precipitate known interactors like Rrp46p

    • Solutions:

      • Use milder lysis and wash buffers

      • Reduce wash stringency while maintaining specificity

      • Include stabilizing agents like glycerol (5-10%) in buffers

      • Consider chemical crosslinking to preserve interactions

  • High background:

    • Problem: Non-specific protein binding obscuring results

    • Solutions:

      • Increase pre-clearing time with beads alone

      • Add competing proteins (BSA) to blocking and wash buffers

      • Use more stringent washes for final wash steps

      • Include appropriate IgG controls

  • Inconsistent results between replicates:

    • Problem: Variable recovery of RRP43 and interacting partners

    • Solutions:

      • Standardize cell growth conditions and lysis procedures

      • Prepare fresh buffers for each experiment

      • Quantify protein content before IP to ensure consistent input

      • Consider automated IP methods for greater reproducibility

When troubleshooting, it's advisable to first test antibodies with epitope-tagged versions of RRP43 (such as those expressed from pCFUS-HARRP43) to establish baseline performance before proceeding to endogenous protein detection.

How should researchers interpret discrepancies between RRP43 antibody results and genetic data?

When researchers encounter discrepancies between results obtained with RRP43 antibodies and genetic approaches, careful interpretation and validation are essential:

  • Analyze antibody specificity comprehensively:

    • Verify antibody recognition using both wild-type and mutant strains

    • Confirm specificity with epitope-tagged versions and genetic knockouts

    • Consider whether the antibody might recognize specific conformations or post-translational modifications

  • Evaluate functional relevance of interactions:

    • Some interactions detected by antibodies may be structurally real but functionally insignificant

    • Compare with phenotypic data from temperature-sensitive mutants (rrp43-1, rrp43-2, rrp43-3)

    • Assess whether interactions occur in physiologically relevant contexts

  • Consider technical limitations of different approaches:

    • Two-hybrid analysis may miss interactions that require additional factors or specific conditions

    • Antibody-based methods might detect indirect interactions within larger complexes

    • Genetic approaches may reveal functional relationships without physical interactions

  • Reconcile conflicting data methodically:

    • Design experiments that directly address the discrepancy

    • Employ orthogonal techniques (e.g., BioID, APEX proximity labeling)

    • Consider whether tissue/cell-type specific or condition-dependent factors may explain differences

The temperature-sensitive RRP43 mutants provide an excellent system for validating antibody results. For instance, if these mutants disrupt interaction with Rrp46p as shown by two-hybrid analysis , antibody-based co-immunoprecipitation should confirm this disruption under non-permissive conditions.

By systematically addressing these considerations, researchers can resolve discrepancies and develop a more complete understanding of RRP43 function within the exosome complex.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.